Invention Grant
- Patent Title: METAP2 inhibitors and methods of treating obesity
-
Application No.: US15993059Application Date: 2018-05-30
-
Publication No.: US10588904B2Publication Date: 2020-03-17
- Inventor: John S. Petersen , James Shanahan
- Applicant: SynDevRx, Inc.
- Applicant Address: US MA Cambridge
- Assignee: SynDevRx, Inc.
- Current Assignee: SynDevRx, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Matthew Pavao
- Main IPC: A61K31/77
- IPC: A61K31/77 ; A61K31/485 ; A61K47/65 ; A61K47/54 ; A61K47/58 ; A61P3/10 ; A61P3/04 ; A61P3/08 ; A61P5/50 ; A61K31/336
Abstract:
The present invention relates to modified or polymer conjugated MetAP2 inhibitors. The present invention also relates to methods of preventing, inducing, causing or increasing weight loss, treating obesity and/or treating metabolic syndrome utilizing the modified or polymer conjugated MetAP2 inhibitors. The present invention also relates to methods of improving insulin sensitivity and glycemic control, reducing insulin levels and/or improving leptin sensitivity utilizing the modified or polymer conjugated MetAP2 inhibitors.
Public/Granted literature
- US20180271856A1 METAP2 INHIBITORS AND METHODS OF TREATING OBESITY Public/Granted day:2018-09-27
Information query
